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We report the cloning and expression of Ac-GST-1, a novel glutathione S-transferase from the adult
hookworm Ancylostoma caninum, and its possible role in parasite blood feeding and as a vaccine target. The
predicted Ac-GST-1 open reading frame contains 207 amino acids (mass, 24 kDa) and exhibited up to 65%
amino acid identity with other nematode GSTs. mRNA encoding Ac-GST-1 was detected in adults, eggs, and
larval stages, but the protein was detected only in adult hookworm somatic extracts and excretory/secretory
products. Using antiserum to the recombinant protein, Ac-GST-1 was immunolocalized to the parasite hypodermis
and muscle tissue and weakly to the intestine. Recombinant Ac-GST-1 was enzymatically active, as determined by
conjugation of glutathione to a model substrate, and exhibited a novel high-affinity binding site for hematin. The
possible role of Ac-GST-1 in parasite heme detoxification during hemoglobin digestion or heme uptake prompted
interest in evaluating it as a potential vaccine antigen. Vaccination of dogs with Ac-GST-1 resulted in a 39.4%
reduction in the mean worm burden and 32.3% reduction in egg counts compared to control dogs following larval
challenge, although the reductions were not statistically significant. However, hamsters vaccinated with Ac-GST-1
exhibited statistically significant worm reduction (53.7%) following challenge with heterologous Necator americanus
larvae. These studies suggest that Ac-GST-1 is a possible drug and vaccine target for hookworm infection.
Hookworm infection is a major cause of disease burden for
animals and humans. An estimated 740 million cases of human
hookworm infection occur worldwide (12). Most of the pathol-
ogy attributed to hookworm infection results from intestinal
blood loss caused by the adult stages of the parasite (21, 32).
The adult hookworm is specially adapted to ingest red blood
cells and feed on the intracellular contents and has evolved to
produce a battery of molecules for this purpose (22, 42). For
instance, the parasite uses its buccal capsule to attach to the
intestinal mucosa and submucosa, where it mechanically ruptures
capillaries and arterioles. From unique cephalic glands, the adult
hookworm releases anticoagulants and anti-platelet-aggregating
agents into the attachment site (10, 34). The parasite subse-
quently ruptures red blood cells through the action of a unique
hemolysin (13) and then degrades the released hemoglobin
through a carefully orchestrated cascade of hemoglobinases (43).
This sequence of events is central to the pathogenesis of hook-
worm disease, which results almost entirely from hookworm-in-
duced blood loss leading to iron deficiency anemia (35).
The trichostrongyle Hemonchus contortus is a major cause of
anemia and weight loss in small ruminants. Like hookworms, H.
contortus produces numerous mechanistically distinct proteases
that are thought to digest hemoglobin (27). Recently, adult H.
contortus was shown to produce a novel glutathione S-transferase
(Hc-GST-1), which has a high-affinity binding site for hematin
(38). The hematin-binding GST is postulated to have a focused
role in the detoxification or transport of heme (derived from the
blood meal) and related compounds and is believed to represent
a special adaptation to blood feeding (38).
Here, we report on the cloning, expression, immunolocaliza-
tion, and heme-binding properties of a GST (Ac-GST-1) pro-
duced by the adult canine hookworm, Ancylostoma caninum. In
addition, we report the results of a canine vaccine trial with
recombinant Ac-GST-1 (rAc-GST-1) followed by A. caninum lar-
val challenge and a hamster vaccine trial followed by heterologous
Necator americanus larval challenge. Our data suggest that Ac-
GST-1 is a promising vaccine candidate and support the hypoth-
esis that targeting the blood-feeding pathway of the adult hook-
worm is a promising vaccine strategy (28, 42).
MATERIALS AND METHODS
Cloning of Ac-gst-1. Larval (first-stage [L1] plus L2 and L3) and adult parasites
of the canine hookworm, A. caninum, as well as their corresponding cDNAs and
cDNA libraries, were obtained and prepared as described previously (17, 24).
Partial cDNA sequence information on Ac-gst-1 was obtained by searching the
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Parasite Genomes Database through Wu-Blast2 (http://www.ebi.ac.uk/blast2
/parasites.html) using the DNA sequence of Sj28, a gene encoding a GST vaccine
antigen from Schistosoma japonicum (18). In order to clone the 5 and 3 cDNA
regions of Ac-gst-1, gene-specific forward primers (Ac-GSTF1, AGA TGT TCG
CTC TTG CTG AC; Ac-GSTF2, TCC TCG AGA AAA GAA TGG TCC ACT
ACA AGC TGA C) and reverse primers (Ac-GSTR1, TGT CTA GAA AGT
GAG TCT CCG GTC TGG TC; Ac-GSTR2, GTA GTC CGT CAT CTG ATC
TG) were designed based on partial expressed sequence tag sequence informa-
tion for Ac-gst-1 obtained from the Parasite Genomes Database. The 5 and 3
regions of Ac-gst-1 cDNA were isolated from the first-strand cDNA of A. cani-
num third-stage infective larvae (L3) by a modified RNA ligase-mediated rapid
amplification technique (GeneRacer; Invitrogen) using Ac-gst-1 gene-specific
primers as described previously (45). The full-length cDNA sequence of Ac-gst-1
was obtained by aligning the 5 and 3 regions of Ac-gst-1 sequences.
Sequence analysis. DNA and predicted protein sequences were analyzed using
ESEE version 3.1 (5). The sequences were aligned using CLUSTAL W (http:
//clustalw.genome.jp) and prepared for display using BOXSHADE (http://bioweb
.pasteur.fr/seqanal/interfaces/boxshade-simple.html).
RT-PCR amplification. Reverse transcription (RT)-PCR was used to deter-
mine the life history stages in which Ac-gst-1 mRNA is transcribed, as described
previously (44). The specific primers Ac-GSTF2 and Ac-GSTR2, based on the
Ac-gst-1 sequence between 35 and 54 bp and 309 and 328 bp, respectively, were
used to amplify Ac-gst-1 cDNA. Genomic DNA of A. caninum was used as a
control.
Expression and purification of the recombinant protein. The full-length
cDNA of Ac-gst-1 was cloned in frame into the eukaryotic expression vector
pPICZA (Invitrogen) using XhoI and XbaI restriction sites. The correct open
reading frame (ORF) was confirmed by sequencing using the vector flanking
primers corresponding to the regions encoding the -factor and 3AOX1 genes.
The recombinant plasmids were linearized by SacI digestion and transformed
into Pichia pastoris strain X-33 by electroporation according to the manufactur-
er’s instructions (Invitrogen). The transformants were selected on zeocin-resis-
tant plates containing yeast extract-peptone-dextrose medium with sorbitol and
identified by PCR amplification using the vector primers described above. A
colony containing the appropriate insert was grown in a shaker flask, and ex-
pression of the recombinant fusion protein containing a polyhistidine tag (His
tag) at the C terminus was induced with methanol, as described previously (14).
The methanol concentration was maintained at 0.5% for 4 days at 28°C. The
recombinant fusion protein was purified with a nickel affinity column as de-
scribed previously (14).
Rabbit anti-rAc-GST-1 antiserum preparation, Western blotting, and immu-
nolocalization. Antiserum against rAc-GST-1 protein was prepared in a rabbit
immunized with four 150-g aliquots of rAc-GST-1 at 3-week intervals as pre-
viously described (45). Antiserum was used in Western blotting to determine
whether the corresponding native protein was present in larval or adult hook-
worms. Extracts of L3, combined L1 plus L2, eggs, adult worms, and adult
excretory/secretory (ES) products, as well as rAc-GST-1, were boiled in sodium
dodecyl sulfate (SDS) sample buffer. Five micrograms of each extract and 8 ng
of rAc-GST-1 were separated on a 4 to 20% gradient SDS precast polyacrylamide
gel (Invitrogen) and subsequently electrotransferred onto a polyvinylidene diflu-
oride membrane (Millipore) (37). Western blotting with a 1:20,000 dilution of
rabbit anti-rAc-GST-1 serum was performed as previously described (45).
For immunolocalization studies, adult A. caninum worms were prepared for
staining as previously described (41). Briefly, sectioned worms were mounted on
glass slides, and nonspecific binding sites were blocked with 5% fetal bovine
serum in phosphate-buffered saline (PBS) containing 0.05% Tween 20 for 1 h.
Antiserum to rAc-GST-1 (1:500 in PBS) was applied to each section and incu-
bated for 2 h at room temperature in a humidified chamber. Normal rabbit
serum (at the same dilution) was used as a negative control. The sections were
washed six times for 5 min each time in PBS and probed with anti-rabbit
Cy3-conjugated immunoglobulin G (IgG) (heavy and light chains) (BD Bio-
sciences) as described previously (41). The sections were viewed with an Olym-
pus BX-60 fluorescence microscope using a 550-nm excitation filter block and
emission at 565 nm.
Assessment of enzymatic activity. The enzyme activity of rAc-GST-1 was
determined according to the method of Habig and Jakoby (15) with 1-chloro-
2,4-dinitrobenzene (CDNB) as a substrate. The enzyme assay was carried out in
a final volume of 0.6 ml containing 45 g rAc-GST-1, 0.1 M phosphate buffer (pH
6.5), 1 mM CDNB, and 1 mM reduced glutathione (GSH). The reaction was
initiated by the addition of the aromatic substrate. The change in absorbance due
to the formation of the glutathione conjugate of CDNB was recorded at 340 nm
once every minute at 25°C. The enzyme activity was expressed as nmol/min/mg
protein.
Ligand binding assays. Ligand binding to rAc-GST-1 was determined by
measuring changes in intrinsic protein fluorescence as described elsewhere (38).
In the binding assays, 1 M rAc-GST-1 was used in 20 mM potassium phosphate
buffer (pH 6.5) containing 100 mM sodium chloride at 25°C. Changes in fluo-
rescence were recorded with a Shimadzu spectrofluorometer (RF-5301 PC) with
excitation and emission wavelengths for intrinsic protein fluorescence (trypto-
phan) of 280 and 320 nm, respectively. Increasing concentrations of hematin
were added and incubated for 3 min prior to measurement.
Animal vaccine trials. Pichia-derived rAc-GST-1 was tested as a vaccine in a
single canine trial (homologous A. caninum larval challenge) and in a single
hamster trial (heterologous N. americanus larval challenge).
(i) Canine trials. The test and control animals were purpose-bred, parasite-
naı¨ve male beagles with ages of 56  7 days on arrival. Inclusion criteria for
enrollment included body weight equal to or exceeding 2.5 kg, hematocrit equal
to or exceeding 28.0, and white blood cell count not exceeding 20  106/ml. All
dogs in a trial were purchased from the same vendor (Harlan Farms) and
maintained in the George Washington University (GWU) Animal Research
Facility as previously described (20). An initial screening fecal examination was
conducted shortly after the arrival of the dogs at the GWU Animal Research
Facility to confirm the absence of canine hookworm infection. The experiments
were conducted according to a protocol (protocol 48-12,1) approved by the
George Washington University Institutional Animal Care and Use Committee.
The dogs were housed in groups for approximately 1 month and at one to three
animals per cage thereafter. Following larval challenge, all dogs were individually
housed.
The dogs were vaccinated with either 100 g of Pichia-expressed rAc-GST-1
formulated with the adjuvant system 03 (AS03; a gift from GlaxoSmithKline
Biologicals) or AS03 only as a control, as described previously (28), under a
protocol approved by the GWU Institutional Animal Care and Use Committee.
The vaccines were administered intramuscularly every 3 weeks on days 0, 21, 42,
and 63. An additional group of five dogs was immunized subcutaneously with
1,000 irradiated A. caninum L3 larvae in 500 l of phosphate-buffered saline
using the same immunization schedule. Two weeks after the final vaccination, the
dogs were challenged with A. caninum L3 by applying 500 infective L3 larvae in
a final volume of 50 l to the footpad (28). Quantitative hookworm egg counts
were performed three times a week starting 14 days after infection. Four weeks
after infection, the dogs were euthanized, and adult hookworms were recovered
at necropsy from the small intestine and colon as described previously (24).
Following the analysis of variance, Dunnett’s test was chosen to compare each
experimental mean with the control mean while controlling the experimental
error rate.
(ii) Hamster trials and N. americanus L3 challenge. The hamster vaccine trial
was performed under a protocol approved by the Institute of Parasitic Diseases
of the Chinese Center for Disease Control and Prevention (IPD-CCDCP). The
IPD-CCDCP has maintained a Chinese strain of N. americanus in golden ham-
sters (Mesocricetus auratus) for more than 100 passages (25). Golden hamsters
aged 5 weeks were obtained from the Shanghai Animal Center, Chinese Acad-
emy of Sciences. Recombinant Ac-GST-1 was used to immunize 20 hamsters by
subcutaneous injection. The dose of rAc-GST-1 given to the hamsters was 25 g,
which was administered once every 2 weeks for a total of three injections. The
adjuvant selected for the hamster trial was Alhydrogel (the IPD-CCDCP has no
contractual arrangements with GlaxoSmithKline for receiving AS03). Another
group of 20 hamsters were immunized only with Alhydrogel as a negative con-
trol. One week after the last immunization, the hamsters were challenged sub-
cutaneously with 150 L3 larvae of N. americanus maintained in hamsters. Twen-
ty-five days postchallenge, hamsters in each group were euthanized, and the
worms were recovered from the intestines. The t test was used for statistical
analysis.
Measurement of canine humoral and cellular immune responses. The dogs
were bled 9 days after each vaccination. Sera were separated and used to mea-
sure levels of antibody isotype (IgG1, IgG2, and IgE) response by an indirect
enzyme-linked immunosorbent assay (ELISA) as described previously (24). The
lymphoproliferation assay was performed using whole-blood culture as previ-
ously described (33). Whole-blood cultures were either unstimulated or stimu-
lated with concanavalin A (ConA) (2.5 g/ml) or rAc-GST-1 (25 g/ml). Cellular
proliferative responses were expressed as a stimulation index (mean proliferation
of stimulated cultures/mean proliferation of unstimulated cultures). Canine in-
terleukin 4 (IL-4), IL-10, and gamma interferon (IFN-) cytokine levels were
measured in supernatants from whole-blood cell cultures. This was done by
incubation of blood cells with hookworm adult extract antigen (25 g/ml), rAc-
GST-1 (25 g/ml), or 1 g/ml of phorbol 12-myristate 13-acetate (Sigma-Aldrich
Co.) and then measuring canine cytokines using a capture ELISA (R&D Sys-
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tems, Minneapolis, MN) according to the manufacturer’s instructions. The t test
was used for statistical analysis.
Nucleotide sequence accession number. The full-length nucleotide sequence
of Ac-gst-1 has been submitted to GenBank with accession number AY605283.
RESULTS
Cloning of Ac-gst-1 cDNA. The 5 and 3 regions of Ac-gst-1
were isolated from A. caninum L3 first-strand cDNA based on
the partial expressed sequence tag sequence (BM077922) ob-
tained from the Parasite Genomes Database. A full-length
743-bp cDNA consensus sequence of Ac-gst-1 was obtained by
linking the 5 and 3 regions generated by 5 and 3 Gene-
Racer. The full-length Ac-gst-1 cDNA comprises an ORF en-
coding 207 deduced amino acids. There is a nematode spliced
leader sequence (SL1) at the 5 end, followed by a translational
start codon (ATG). The predicted Ac-GST-1 protein has a
calculated molecular mass of 23.75 kDa and a theoretical pI of
5.87. One putative N-linked glycosylation site (Asn-X-Ser) was
located between amino acids 144 and 146. InterPro database
searching at EMBL-EBI revealed that Ac-GST-1 is a member
of the GST superfamily containing typical GST N-terminal
(IRP004045) and C-terminal (IRP004046) domain structures,
including conserved tyrosine residues in the N-terminal do-
main (Tyr-4 and Tyr-8).
An alignment of the putative Ac-GST-1 ORF with GST
homologues from other nematodes, S. japonicum, and human
GST-3 is shown in Fig. 1; it demonstrates that Ac-GST-1
exhibits 65% identity with HpGST2 (Heligmosomoides polygy-
rus), 58% identity with Hc-GST-1 (H. contortus) and Ce-GST-5
(Caenorhabditis elegans), 31% with Sj28 (S. japonicum), and
27% with human GST-3.
RT-PCR analysis. The Ac-gst-1-specific primers Ac-GSTF2
and Ac-GSTR2, based on the Ac-gst-1 sequence between 35
and 328 bp, were employed to amplify Ac-gst-1 cDNA reverse
transcribed from mRNAs of different developmental life his-
tory stages of A. caninum (Fig. 2). A 294-bp cDNA product was
amplified from the cDNAs obtained from A. caninum eggs, L1
plus L2, L3, and adult hookworms, indicating that Ac-gst-1
mRNA is transcribed throughout development. A band with
an approximate size of 700 bp was observed in the reaction
with genomic DNA, suggesting the amplification of an in-
tron(s) (Fig. 2).
Detection and immunolocalization of native Ac-GST-1 in A.
caninum. Recombinant Ac-GST-1 was expressed in Pichia
strain X-33, purified by nickel affinity chromatography, and
used to raise antiserum for detection of the native protein in
the parasite. On a Western blot, a single strong band migrating
with an apparent mass of 30 kDa was recognized by the anti-
serum in the extract of adult A. caninum (Fig. 3). A band of the
same size was also observed in the ES products of adult hook-
worms. The molecular masses of native Ac-GST-1 observed in
Western blots were approximately 6 kDa greater than the
predicted molecular mass of the ORF. This may indicate post-
translational modifications, such as glycosylation at Asn-144.
FIG. 1. Alignment of the deduced amino acid sequence of Ac-GST-1 with those of putative homologues from Heligmosomoides polygyrus
(HpGST2; GenBank accession no. AAF36480), C. elegans (Ce-GST-5; NP_496357), H. contortus (Hc-GST-1; AAF81283), and S. japonicum (Sj28;
P26624) and human GST-3 (A49365). The sequences were aligned using CLUSTAL W and prepared for display using BOXSHADE. Identical
amino acids are shaded in black, and similar amino acids in gray. Conserved tyrosine residues (Tyr-4 and Tyr-8) are marked with asterisks. The
percentage of sequence identity to Ac-GST-1 is shown at the end of each sequence.
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The molecular mass of rAc-GST-1 was approximately 3 kDa
higher than that of the native protein, presumably because of
a His tag expressed at the C terminus. The absence of addi-
tional major bands in the lane containing the recombinant
protein suggested there was no evidence for major contamina-
tion of the purified rAc-GST-1 with Pichia host cell contami-
nants. This was confirmed by an ELISA and Western blot test
that employs an antibody to Pichia pastoris proteins (Immu-
noenzymatic assay kit and Western blot kit; Cygnus Technol-
ogies, Southport, NC) (data not shown). In contrast to adult
hookworms and their ES, no band on Western blots was rec-
ognized by the anti-rAc-GST-1 rabbit serum in the extracts of
L3, L1 plus L2, and eggs (Fig. 3). Immunolocalization studies
revealed that anti-rAc-GST-1 antiserum bound strongly to the
adult parasite hypodermis (Fig. 4A) and muscle (Fig. 4B) and
weakly to the gastrointestinal tract (Fig. 4B). No significant
staining was observed using normal rabbit serum (Fig. 4C).
Enzymatic and ligand binding activities of rAc-GST-1. The
enzymatic activity of rAc-GST-1 with a His tag catalyzing the
conjugation of GSH to CDNB substrate was estimated to be
844.93  23.43 nmol/min/mg (mean of duplicates  standard
deviation), indicating that Ac-GST-1 functions as a glutathione
transferase in vitro (Table 1). No activity was observed with the
same quantity of an irrelevant control, recombinant Ancylos-
toma-secreted protein 2 from Necator americanus (Na-ASP-2).
The high degree of amino acid alignment between Ac-GST-1
and Hc-GST-1, a heme-binding GST from H. contortus (38),
suggests that the former could also exhibit heme-binding prop-
erties. On a Western blot, rabbit anti-rAc-GST-1 serum also
showed cross-reaction with recombinant Hc-GST-1 (data not
shown). Recombinant six-His-tagged Ac-GST-1 was observed
to bind to hematin and its precursor, protoporphyrin IX, by a
double-reciprocal-plot quenching of intrinsic fluorescence as-
say (Fig. 5A and B). The dissociation constant (Kd) values for
hematin and for protoporphyrin IX are 2.3  0.38 M and
19.98  4.48 M, respectively. This indicates that rAc-GST-1
has almost 10-times-higher binding activity to hematin than to
protoporphyrin IX, the structurally related precursor that does
not contain iron. The 50% inhibitory concentration of hematin
for the GSH-CDNB conjugation catalyzed by rAc-GST-1 was
determined to be 3.23  0.1 M, indicating that hematin and
CDNB share the same binding site on the GST.
Canine antibody and cellular responses to rAc-GST-1 im-
munization. Dogs vaccinated with rAc-GST-1 formulated with
AS03 adjuvant produced high IgG1 and IgG2 antibody re-
sponses in an indirect ELISA (Fig. 6). The highest geometric
mean antibody titers for IgG1 (1:13,500) and IgG2 (1:40,500)
were observed after the fourth vaccination. Both IgG1 and
IgG2 titers declined after the canines were challenged with L3.
Ac-GST-1-specific IgE titers were low (1:500) (data not
shown). Control dogs (adjuvant AS03 alone) did not generate
detectable anti-rAc-GST-1 immune responses (data not
shown). Peripheral blood leukocytes (PBLs) from dogs vacci-
nated with rAc-GST-1 proliferated in the presence of rAc-
GST-1, while PBLs from dogs immunized with adjuvant alone
did not proliferate. The mean stimulation index for the vacci-
nated dogs was 2.36 times higher than that for the negative
control dogs (P 0.05) (Fig. 7A). PBLs from both groups were
stimulated equally with ConA, indicating that the PBLs were
functional and responsive to nonspecific mitogens at all time
points tested (Fig. 7A). PBLs from dogs vaccinated with rAc-
GST-1 produced 9.1  2.9 ng/ml of IFN- after antigen-spe-
cific stimulation compared to control dogs (AS03 only), which
produced only 3.3  1.4 ng/ml (P  0.05) (Fig. 7B). The
peripheral leukocytes from the vaccinated group also produced
significantly higher IFN- levels after being stimulated with
adult worm extract than those of controls (P  0.04). In con-
trast, there were no significant differences in the production of
IL-4 (Fig. 7B) or IL-10 (data not shown) induced by rAc-
GST-1, even though IL-4 was significantly induced by hook-
worm adult extract in the vaccinated dogs (P  0.04).
Postchallenge reductions in hookworm burdens and fecal
egg counts. Two weeks after the immunization series was com-
pleted, both Ac-GST-1/AS03-vaccinated dogs and AS03-in-
jected dogs were challenged percutaneously with 500 A. cani-
FIG. 2. Stage specificity of Ac-gst-1 mRNA. RT-PCR was per-
formed on total RNA isolated from the adult worms, L3, L1 plus L2,
and eggs of A. caninum. Specific primers for Ac-gst-1 (Ac-GSTF2 and
Ac-GSTR2) were used for amplification. Adult hookworm genomic
DNA (gDNA) was used as a control. Lane dH2O (distilled H2O),
negative (no-template) control.
FIG. 3. Identification of the native Ac-GST-1 by Western blotting
with antiserum raised to rAc-GST-1. Five-microgram extracts from
adults, L3, L1 plus L2, eggs, and ES products of the adult worm A.
caninum were homogenized in SDS-polyacrylamide gel electrophore-
sis sample buffer, subjected to electrophoresis, and transferred to a
polyvinylidene difluoride membrane. Eight nanograms of rAc-GST-1
protein was used as a positive control. The Western blot was probed
with rabbit antiserum against rAc-GST-1.
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num L3 larvae. The numbers of adult A. caninum parasites
recovered from the small and large intestines of the vaccinated
dogs were reduced by 39.4% compared with those from dogs
immunized with adjuvant alone. Reductions in fecal egg counts
(32.3%) were also observed in the feces of dogs vaccinated
with rAc-GST-1 compared with those of adjuvant control dogs
(Table 2). However, because the variation in the numbers of
worms and eggs recovered from both the vaccinated and con-
trol groups was high, the reduction rates were not statistically
significant. Dogs vaccinated with irradiated L3 larvae exhibited
a mean 48.9% worm burden reduction and 56% egg reduction.
The former was statistically significant (P  0.05) using Dun-
nett’s test compared with control dogs.
In a second trial using an N. americanus challenge model in
golden hamsters, the rAc-GST-1/Alhydrogel-vaccinated ham-
sters exhibited a 53.7% adult worm reduction in the intestines
compared to Alhydrogel-injected control hamsters (P  0.05)
(Table 3). Two of the vaccinated hamsters died unexpectedly
during the trial. It was noted that both of the hamsters exhib-
ited substantially reduced body weights, which appeared to
result from decreased feeding because of a broken tooth. The
results indicate that rAc-GST-1 exhibits cross-protective im-
munity against N. americanus in hamsters.
DISCUSSION
Here, we report on the cloning and function of a unique
glutathione transferase from the hookworm, A. caninum; its
possible role in blood feeding; and its potential as a vaccine
antigen. This is the first report of the cloning of a full-length
cDNA encoding hookworm GST.
Like other members of the GST superfamily, including nem-
atode and trematode GSTs, Ac-GST-1 contained typical GST
N-terminal (IRP004045) and C-terminal (IRP004046) domain
structures. Ac-GST-1 also contained both Tyr-4 and Tyr-8 in
the N-terminal region, which are highly conserved in mamma-
lian and helminth GSTs (19). Tyr-8 is predicted to be essential
for catalytic activity (8). The full-length Ac-GST-1 shares 31%
identity at the amino acid level with Sj28, a protective schisto-
some GST that is undergoing clinical trials as a human vaccine
for schistosomiasis (6).
Although Ac-gst-1 mRNA was detected in several develop-
mental life history stages of A. caninum (including L1, L2, L3,
adult, and egg), and the Ac-gst-1 cDNA was cloned from L3
cDNA, Ac-GST-1 protein was detectable by Western blotting
only in adult hookworm somatic extracts and adult ES prod-
ucts. This suggests that Ac-gst-1 mRNA might be transcribed
but not translated in the non-blood-feeding stages or expressed
at such a low level that it cannot be detected with antibody.
Helminth GSTs have been reported from every developmental
stage (31, 39, 40); however, one helminth GST from the lung
fluke, Paragonimus westermani, was expressed only by adult
flukes (19). The adult-specific expression of Ac-GST-1 protein
suggests that the protein may play an important role in the
survival of the adult worm in the host during blood feeding.
Immunolocalization with specific antiserum confirmed that
Ac-GST-1 mainly localized in the hypodermis and muscle tis-
sue of the adult worm. Ac-GST-1 was also observed weakly in
the intestine, consistent with the finding of Ac-GST-1 in the ES
FIG. 4. Immunolocalization of Ac-GST-1 in sections of adult A. caninum. Fluorescence was detected with a Cy3-conjugated anti-rabbit IgG
serum. Longitudinal sections of adult A. caninum worms probed with anti rAc-GST-1 serum showed Ac-GST-1 localized intensively to the
hypodermis (A) and muscular tissue (B) and weakly to the intestine (B) (arrows). Normal rabbit serum with the same dilution was used as a control
(C).
TABLE 1. Glutathione transferase activity of rAc-GST-1
Protein Sp act (mol/min/mg)a
rAc-GST-1 .................................................................... 844.93  23.43
rNa-ASP-2 .................................................................... 0
dH2O
b ........................................................................... 0
a The results represent the mean of the two determinations  SD.
b dH2O, distilled H2O.
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products of the adult hookworm. The detection of Ac-GST-1 in
the hypodermis, intestine, and adult ES products suggests that
it not only functions as an intracellular cytosolic housekeeping
enzyme, but is also acting at the host-parasite interface and
could function in blood feeding and other parasitic roles.
The glutathione transferases are detoxification enzymes that
catalyze the conjugation of the tripeptide GSH to endogenous
and xenobiotic electrophilic toxins. Based on this enzymatic
activity, many parasitic helminth GSTs play an important role
in detoxifying the secondary products of lipid peroxidation
produced via immune-initiated free-radical attack on host or
parasite membranes (3, 7, 26). In this sense, helminth GSTs
are immunomodulatory. However, similar to the Hc-GST-1
produced by the adult blood-feeding helminth H. contortus, the
Pichia-expressed rAc-GST-1 possessed little glutathione-de-
pendent peroxidase activity or conjugating activity with cyto-
toxic carbonyls, products of lipid peroxidation (results not
shown). Therefore, both Ac-GST-1 and Hc-GST-1 may not be
much involved in immunomodulation compared to GSTs from
cestode and digegean parasites (3, 4).
The GSTs from blood feeding nematodes (Ac-GST-1 and
Hc-GST-1) were noted to contain a high-affinity binding site
for hematin and heme-related compounds (38) (Fig. 5). In
contrast, a GST homologue from the closely related free-living
nematode C. elegans has a weak affinity for hematin (38).
Together with the adult-stage-specific expression of Ac-GST-1,
as well as its secretion in ES products, our findings suggest that,
just like Hc-GST-1, adult A. caninum worms employ GST-1 in
processes linked to blood-feeding behavior, including the de-
toxification of heme released during hemoglobin digestion.
Like many blood-feeding parasites, such as Plasmodium sp.,
Schistosoma sp., and Hemonchus sp., that depend on the globin
portion of hemoglobin for nutrition (42), hookworms have
evolved a carefully orchestrated cascade of hemoglobin diges-
tion (43). However, this stepwise degradation of hemoglobin
results in the release of heme, which is a potent enzyme inhib-
itor and generator of toxic reactive oxygen species (29). Adult
A. caninum worms may produce Ac-GST-1 to assist in remov-
ing and/or scavenging hematin or heme-related compounds
generated during hemoglobin digestion. The GST from Plas-
modium falciparum has also been shown to bind and detoxify
heme compounds and serves as an efficient buffer for detoxi-
fying it (2, 16). Ac-GST-1 also binds protoporphyrin IX, the
structurally related precursor of hematin that does not contain
free iron and therefore is not toxic. However, the binding
affinity to protoporphyrin IX was almost 10 times lower than
the binding affinity to hematin (Fig. 5). This observation fur-
ther suggests that Ac-GST-1 might selectively bind and detox-
ify hematin rather than the nontoxic precursor.
The schistosome GST is currently a leading vaccine candi-
date for human schistosomiasis (9, 36) and is undergoing a
FIG. 5. Binding of rAc-GST-1 to hematin (A) and its precursor,
protoporphyrin IX (B), as demonstrated by double-reciprocal-plot
quenching of intrinsic fluorescence in rAc-GST-1 (Q) against the con-
centrations of free hematin (Hf) and free protoporphyrin IX (Pf). The
intrinsic fluorescence Kd values for binding hematin and protoporphy-
rin IX are 2.3  0.38 M and 19.98  4.48 M, respectively. The data
shown are averages of three determinations with standard deviations.
FIG. 6. Geometric mean titers of the IgG1 and IgG2 antibody
responses of vaccinated dogs against rAc-GST-1 formulated with AS03
adjuvant. Vaccination times (1, 2, 3, and 4) and challenge day (C) are
marked with arrows.
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phase II clinical trial (6). Because of its putative importance in
blood feeding, Ac-GST-1 is a potential drug and vaccine target.
The hookworm vaccine trials reported here indicate that
Pichia-expressed rAc-GST-1 is highly immunogenic and in-
duces not only Th2-associated antibody (IgG1) and cytokine
(IL-4) responses, but also a strong Th1-like response indicated
by the production of IFN-, as well as IgG2 antibody response.
Although a link between IFN- and IgG2 exists in humans and
mice, the link has not been established for dogs. However,
experimental evidence from published canine studies does in-
dicate an association between isotype production and possible
Th1/Th2 shifts (1, 11, 30). Recombinant Ac-GST-1 also in-
duced a strong proliferative response in PBLs. Dogs vaccinated
with rAc-GST-1 exhibited a marked reduction in adult hook-
worm burdens and egg counts compared with the control dogs,
although they were not sufficient to show statistical significance
because of variation in worm recovery and egg counts. This
partly reflected the small sample size of dogs used in the trial,
which was limited in scope because of the expense and ethics of
employing larger numbers of this sensitive species. However,
hamsters vaccinated with rAc-GST-1 showed 53.7% reduction
in hookworm burden after being challenged with the human
hookworm N. americanus. The statistical significance of the
hamster trial partly reflects the comparatively large numbers of
animals (20 in each group) used in the study. The results from
the hamster trial indicate that Ac-GST-1 and its N. americanus
orthologue presumably share sufficient identity to produce im-
munological cross-reactivity. However, we cannot rule out the
possibility that the improved protection in hamsters also re-
flected differences in the adjuvant employed.
Our overall strategy to vaccinate against human hookworm
disease is based on employing two different antigens, one that
targets the larval stage to reduce the numbers of L3 larvae
entering the gastrointestinal tract, the other targeting adult
blood feeding (20, 23). The L3-secreted protein, ASP-2, is our
lead larval vaccine antigen (14), while a cathepsin B hemoglo-
binase has shown promise as an adult vaccine antigen (28).
These studies suggest that members of the GST family could
also be used as adult hookworm vaccine candidate molecules.
Western blotting with rabbit anti-rAc-GST-1 could not recog-
nize mouse GST in the liver cytosol (data not shown), indicat-
ing limited or no cross-reaction between hookworm and mam-
malian GSTs. The identification and cloning of an Ac-GST-1
homologue from N. americanus, the major human hookworm
worldwide, is now in progress.
FIG. 7. Cellular immune responses of dogs to vaccination with rAc-GST-1. (A) rAc-GST-1-specific proliferation responses of peripheral
leukocytes from vaccinated dogs. The results are shown as the stimulation index (S.I.) for each dog, and the geometric mean value for each group
is indicated by a bar. The P value between results for dogs vaccinated with rAc-GST-1 and adjuvant alone is given above the mean. ConA was used
as a mitogen control at all time points tested. (B) Detection of IL-4 and IFN- in peripheral blood leukocytes of rAc-GST-1-vaccinated dogs primed
with NS (no stimulus), GST (rAc-GST-1), AE (adult worm extracts), and PMA (phorbol 12-myristate 13-acetate). The numbers shown above the
bars are the P values between results obtained for dogs vaccinated with rAc-GST-1 and adjuvant alone. The error bars represent standard
deviations.
TABLE 2. Reduction of adult A. caninum hookworms and fecal
egg counts from dogs vaccinated with rAc-GST-1 and radiated L3
Vaccine group No. ofdogs
Worms EPGa
Mean  SE %Reduction Mean  SE
%
Reduction
AS03 control 5 137  29 3,500  1149
Ac-GST-1 5 83  13 39.4 2,370  626 32.3
Irradiated L3 5 70  23 48.9b 1,540  741 56.0
a EPG, number of eggs per gram of feces.
b P  0.05.
TABLE 3. Reduction of adult N. americanus hookworms recovered
from the intestines of hamsters vaccinated with rAc-GST-1
Vaccine group No. of hamsters
Worms
Mean  SE % Reduction
Adjuvant control 20 33.9  3.4
Ac-GST-1 18 15.7  2.3 53.7a
a P  0.05.
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